14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.500 $0.720 Thursday, 25th Apr 2024 ADXS stock ended at $0.550. This is 1.85% more than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 0% from a day low at $0.550 to a day high of $0.550.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Aug 20, 2020 $0.530 $0.530 $0.465 $0.478 1 010 174
Aug 19, 2020 $0.507 $0.519 $0.480 $0.490 1 365 578
Aug 18, 2020 $0.505 $0.525 $0.501 $0.507 936 532
Aug 17, 2020 $0.530 $0.535 $0.501 $0.513 1 435 523
Aug 14, 2020 $0.540 $0.554 $0.520 $0.523 751 753
Aug 13, 2020 $0.545 $0.550 $0.525 $0.533 774 056
Aug 12, 2020 $0.560 $0.561 $0.540 $0.545 666 127
Aug 11, 2020 $0.590 $0.590 $0.555 $0.557 747 696
Aug 10, 2020 $0.550 $0.580 $0.550 $0.574 908 123
Aug 07, 2020 $0.565 $0.570 $0.534 $0.550 1 088 133
Aug 06, 2020 $0.587 $0.587 $0.551 $0.570 667 094
Aug 05, 2020 $0.581 $0.585 $0.565 $0.573 720 732
Aug 04, 2020 $0.579 $0.590 $0.565 $0.575 1 047 277
Aug 03, 2020 $0.585 $0.620 $0.565 $0.573 1 306 932
Jul 31, 2020 $0.601 $0.609 $0.580 $0.580 515 647
Jul 30, 2020 $0.570 $0.610 $0.570 $0.594 958 205
Jul 29, 2020 $0.600 $0.600 $0.570 $0.600 628 718
Jul 28, 2020 $0.575 $0.600 $0.561 $0.595 483 314
Jul 27, 2020 $0.575 $0.600 $0.570 $0.585 560 614
Jul 24, 2020 $0.598 $0.600 $0.550 $0.598 842 701
Jul 23, 2020 $0.605 $0.640 $0.591 $0.600 1 253 258
Jul 22, 2020 $0.633 $0.634 $0.590 $0.600 784 500
Jul 21, 2020 $0.660 $0.660 $0.610 $0.629 1 554 800
Jul 20, 2020 $0.580 $0.654 $0.575 $0.629 2 759 700
Jul 17, 2020 $0.560 $0.575 $0.544 $0.561 1 618 100
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT